Carlat Publishing Blog

From a public health standpoint, ADHD is worse than the top five killers in the U.S. combined. Russell Barkley, PhD, is a Clinical Professor of Psychiatry at the Virginia Commonwealth University Medical Center (VCUMC), Richmond, VA. His research findings have lit a...

With two medications approved for tardive dyskinesia, how do you choose between them? And how does anyone afford their $80-140,000 a year price tag? We'll walk you through the steps, and show you how to get these VMAT2 inhibitors approved...

Esketamine (Spravato) was approved in 2019 for treatment resistant depression, but the medicine quickly gathered controversy about its long-term safety. We interview Dr. Nolan Williams from Stanford University about these issues and where esketamine fits in our interventions for treatment...

These are the articles from 2019 that changed our practice. Dark therapy for mania. CBD oil. Genetic testing. An antidepressant diet. Viagra and the brain. Sleep in PTSD. Antidotes for weight gain and nausea. Light therapy for depression. Date Published:...

When a patient is diagnosed with ADHD for the first time in adulthood, they have a lot of baggage to overcome. Years of living with the symptoms has probably shaped their identity, and in part 2 of our interview with...